How effective is the magnesium for preeclampsia?
The use of magnesium for preeclampsia has proved to be much more effective than other treatment generally administered to prevent more serious conditions, such as Ectober and seizures. Eclampsia is the final phase of preeclampsia and is considered to be the most threatening life for a pregnant woman and her unborn child. It is estimated that on average two to three times less women experience seizures of magnesium sulphate than those who use traditional drugs. This is true when the drug is administered intravenously and only in women with severe forms of the condition rather than in women with mild to medium preeclampsia.
When using magnesium for preeclampsia, the results showed, it is strongly discussed when or whether its use is guaranteed. Some argue that all women with preeclampsia should be administered by magnesium sulphate to prevent deterioration. However, the research has indicated that eclampsia and the resulting seizures are rare relays, so the risks associated with the use of magnesium for preeclampsia in its earliest stages are not guaranteed.
The overall risk factors of using magnesium sulphate in pregnant or working mother are not fully understood. It should be noted that the drug releases muscle tissue and is considered useful in preventing premature birth. For a mother who is full of periods, this could cause problems by prolonging her work and increasing her risks for interventions, such as caesarean section or delivery of pliers. Tests have also shown that during treatment with preeclampsia, the drug passes through the placenta in a sufficiently large volume to achieve the fetus. The complications of this placental transition could cause them not yet known.
Most arguments against the use of a routine magnesium for preeclampsia relate to the uncertain risks that the drug can cause. To determine what RI is needed more studies, if at all, it can introduce it to the mother and her unborn child. Research has provided mixed results so far, some of which show pIrrivable results for infants and other showing fetal mortality.
is on every mother and her medical team to determine whether the use of magnesium sulphate is a good procedure for treatment for mild to severe preeclampsia. The risks and potential advantages should be discussed in detail to allow each mother to decide the correct decision. Careful monitoring of the mother and the child should continue throughout pregnancy, work and after delivery to ensure that there is no complications. In most cases, it is recommended that the use of magnesium and all other medicines be reserved for serious situations.